Cargando…
Usefulness of Midregional Proadrenomedullin to Predict Poor Outcome in Patients with Community Acquired Pneumonia
BACKGROUND: midregional proadrenomedullin (MR-proADM) is a prognostic biomarker in patients with community-acquired pneumonia (CAP). We sought to confirm whether MR-proADM added to Pneumonia Severity Index (PSI) improves the potential prognostic value of PSI alone, and tested to what extent this com...
Autores principales: | Gordo-Remartínez, Susana, Calderón-Moreno, María, Fernández-Herranz, Juan, Castuera-Gil, Ana, Gallego-Alonso-Colmenares, Mar, Puertas-López, Carolina, Nuevo-González, José A., Sánchez-Sendín, Domingo, García-Gámiz, Mercedes, Sevillano-Fernández, José A., Álvarez-Sala, Luis A., Andueza-Lillo, Juan A., de Miguel-Yanes, José M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452655/ https://www.ncbi.nlm.nih.gov/pubmed/26030588 http://dx.doi.org/10.1371/journal.pone.0125212 |
Ejemplares similares
-
Midregional Proadrenomedullin Can Reflect the Accumulation of Visceral Adipose Tissue—A Key to Explaining the Obesity Paradox
por: Koyama, Teruhide, et al.
Publicado: (2020) -
Kinetics and Role of Pancreatic Stone Protein and Midregional Proadrenomedullin as Predictors of Sepsis and Bacteremia in Children with Hematological Malignancies
por: Antari, Vasiliki, et al.
Publicado: (2023) -
Sensitivity and Specificity of Soluble Triggering Receptor Expressed on Myeloid Cells-1, Midregional Proatrial Natriuretic Peptide and Midregional Proadrenomedullin for Distinguishing Etiology and to Assess Severity in Community-Acquired Pneumonia
por: Esposito, Susanna, et al.
Publicado: (2016) -
Midregional Proadrenomedullin Improves Risk Stratification beyond Surgical Risk Scores in Patients Undergoing Transcatheter Aortic Valve Replacement
por: Csordas, Adam, et al.
Publicado: (2015) -
Midregional Proadrenomedullin (MRproADM) Serum Levels in Critically Ill Patients Are Associated with Short-Term and Overall Mortality during a Two-Year Follow-Up
por: Buendgens, Lukas, et al.
Publicado: (2020)